CD4 and kidney cancer: NEIL3 showed a positive correlation with six types of immune cells in three cancer subgroups (pan-kidney cancer cohort (KIPAN, including KICH, KIRC, and KIRP), KIRC, and LIHC), involving B cells, CD8 T cells, CD4 T cells, DCs, macrophages, and neutrophils (Figure 6A).